| Miles City Vision Clinic P C | |
|
1909 Main St, Miles City, MT 59301-3724 | |
| (406) 234-7426 | |
| (406) 234-7005 |
| Full Name | Miles City Vision Clinic P C |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1909 Main St, Miles City, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215006416 | NPI | - | NPPES |
| 0482807 | Medicaid | MT | |
| 0481039 | Medicaid | MT | |
| 0481546 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 500 (Montana) | Primary |
| Provider Name | Lynn A Carlo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205801776 PECOS PAC ID: 4183522428 Enrollment ID: I20120220000395 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
With the FDA's recent approval of an artificial disc that makes spinal fusion "a thing of the past," one nationally renowned spine surgeon is receiving a flood of phone calls from patients interested in seeking relief from chronic back pain.
Democrats and Republicans alike are girding for the unveiling of the 2013 budget plan by House Budget Committee Chairman Paul Ryan, R- Wis., and its provisions to overhaul Medicare.
Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.
A new study published in the online journal Gut suggested that the prolonged use of proton pump inhibitors (PPIs) that are mainly utilized in treating acid reflux is associated with more than a two-fold increase in the risk of gastric cancer.
› Verified 1 days ago
| Provider Name | Ashley Nicole Watson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043673189 PECOS PAC ID: 7810260874 Enrollment ID: I20170913002699 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
With the FDA's recent approval of an artificial disc that makes spinal fusion "a thing of the past," one nationally renowned spine surgeon is receiving a flood of phone calls from patients interested in seeking relief from chronic back pain.
Democrats and Republicans alike are girding for the unveiling of the 2013 budget plan by House Budget Committee Chairman Paul Ryan, R- Wis., and its provisions to overhaul Medicare.
Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.
A new study published in the online journal Gut suggested that the prolonged use of proton pump inhibitors (PPIs) that are mainly utilized in treating acid reflux is associated with more than a two-fold increase in the risk of gastric cancer.
› Verified 1 days ago
| Provider Name | Laurel Rose Rub Schimelfening |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376035493 PECOS PAC ID: 0547510273 Enrollment ID: I20180830000888 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
With the FDA's recent approval of an artificial disc that makes spinal fusion "a thing of the past," one nationally renowned spine surgeon is receiving a flood of phone calls from patients interested in seeking relief from chronic back pain.
Democrats and Republicans alike are girding for the unveiling of the 2013 budget plan by House Budget Committee Chairman Paul Ryan, R- Wis., and its provisions to overhaul Medicare.
Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.
A new study published in the online journal Gut suggested that the prolonged use of proton pump inhibitors (PPIs) that are mainly utilized in treating acid reflux is associated with more than a two-fold increase in the risk of gastric cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miles City Vision Clinic P C 1909 Main St, Miles City, MT 59301-3724 Ph: (406) 234-7426 | Miles City Vision Clinic P C 1909 Main St, Miles City, MT 59301-3724 Ph: (406) 234-7426 |
News Archive
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
With the FDA's recent approval of an artificial disc that makes spinal fusion "a thing of the past," one nationally renowned spine surgeon is receiving a flood of phone calls from patients interested in seeking relief from chronic back pain.
Democrats and Republicans alike are girding for the unveiling of the 2013 budget plan by House Budget Committee Chairman Paul Ryan, R- Wis., and its provisions to overhaul Medicare.
Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.
A new study published in the online journal Gut suggested that the prolonged use of proton pump inhibitors (PPIs) that are mainly utilized in treating acid reflux is associated with more than a two-fold increase in the risk of gastric cancer.
› Verified 1 days ago
Ashley Watson, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1909 Main St, Miles City, MT 59301 Phone: 406-234-7426 | |
Dr. Lynn Ann Carlo, O D Optometrist Medicare: Medicare Enrolled Practice Location: 1909 Main St, Miles City, MT 59301 Phone: 406-234-7426 Fax: 406-234-7005 | |
Laurel Rose Rub Schimelfening, OD, MEDVFL Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1909 Main St, Miles City, MT 59301 Phone: 406-234-7426 | |
Dr. Robert Dean Lunde, O D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1909 Main St, Miles City, MT 59301 Phone: 406-234-7426 Fax: 406-234-7005 | |
Albert John Sparr, O D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1909 Main St, Miles City, MT 59301 Phone: 406-234-7426 Fax: 406-234-7005 |